Showing results (11-20 of 22) with videos related to
Sort By:
Pageof 3
Plos Pathogens|September 5, 2023
Polypharmacology-based kinome screen identifies new regulators of KSHV reactivationAnnabel T Olson, Yuqi Kang, Anushka M Ladha, et al.Nature Biotechnology|April 20, 2026
Comprehensive profiling of clinically approved kinase inhibitors reveals mutation-specific inhibitors and opportunities for drug repurposingMehlam Saifudeen, Songli Zhu, Shuguang Liang, et al.Journal of Cell Science|March 26, 2025
γ-tubulin mediates DNA double-strand break repairAbhishikt David Solomon, Odjo G Gouttia, Ling Wang, et al.Biorxiv : the Preprint Server for Biology|December 22, 2025
Subtype-Specific Dependencies and Drug Vulnerabilities Enable Precision Therapeutics in Head and Neck CancerJoel Vaz, Songli Zhu, Mateo Useche, et al.Ejhaem|December 18, 2024
A phase 2 study of frontline pembrolizumab in follicular lymphomaCarrie Ho, Songli Zhu, Ted Gooley, et al.Gut|April 24, 2025
DNAJ-PKAc fusion heightens PLK1 inhibitor sensitivity in fibrolamellar carcinomaMarina Chan, Songli Zhu, Manabu Nukaya, et al.NPJ Precision Oncology|May 25, 2026
Transcriptional states define dependencies and therapeutic vulnerabilities in head and neck cancerJoel M Vaz, Songli Zhu, Mateo Useche, et al.Proceedings of the National Academy of Sciences of the United States of America|February 10, 2026
A systems approach identifies MERTK as a therapeutic vulnerability in ZFTA-RELA-driven ependymomasMarina Chan, Songli Zhu, Zachary R Russell, et al.JCI Insight|May 23, 2023
High-fat diet plus HNF1A variant promotes polyps by activating β-catenin in early-onset colorectal cancerHeyu Song, Ricky A Sontz, Matthew J Vance, et al.Cell Reports. Medicine|September 20, 2025
Drug screening in 3D microtumors reveals DDR1/2-MAPK12-GLI1 as a vulnerability in cancer-associated fibroblastsNao Nishida-Aoki, Songli Zhu, Marina Chan, et al.Pageof 3